Inbios International, Inc. was awarded a definitive cost-plus-fixed-fee contract valued at $11,988,614 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The base period award is to provide point-of-care immunoassay for diagnosis of inhalational anthrax, as requested in the original solicitation. Inbios, a minority-owned small business based in Seattle, Washington, will manufacture and deliver rapid diagnostic tests to detect exposure to Bacillus anthracis, the bacterium that causes anthrax. The contract has a period of performance through August 2025. Inbios has extensive experience developing immunodiagnostic devices for infectious diseases and biothreats through previous contracts with HHS and other federal agencies.
Generated 2/24/24, 11:11 AM